Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene
US8022197B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 16, 2004 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | Dec 15, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/203
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to a gene derived from a novel fulminant hepatitis C virus strain, an HCV replicon RNA with a high replication efficiency obtained using the gene, and an HCV replicon-replicating cell transfected with the replicon RNA. When the HCV replicon RNA and the HCV replicon-replicating cell of the present invention are used, HCV proteins can be continuously produced in a large amount.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.